Go Pro

Genpact (G) Competitors

Genpact logo
$37.70 -0.28 (-0.74%)
As of 09/1/2026 03:58 PM Eastern

G vs. EXLS, BR, SSNC, MMS, and INOD

Should you buy Genpact stock or one of its competitors? Genpact's main competitors and comparable companies include ExlService (EXLS), Broadridge Financial Solutions (BR), SS&C Technologies (SSNC), Maximus (MMS), and Innodata (INOD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "data processing & outsourced services" industry.

How does Genpact compare to ExlService?

Genpact (NYSE:G) and ExlService (NASDAQ:EXLS) are both mid-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, ExlService had 2 more articles in the media than Genpact. MarketBeat recorded 17 mentions for ExlService and 15 mentions for Genpact. ExlService's average media sentiment score of 1.41 beat Genpact's score of 0.70 indicating that ExlService is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genpact
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
ExlService
14 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

96.0% of Genpact shares are owned by institutional investors. Comparatively, 92.9% of ExlService shares are owned by institutional investors. 1.6% of Genpact shares are owned by insiders. Comparatively, 3.7% of ExlService shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Genpact has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market. Comparatively, ExlService has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

ExlService has a net margin of 11.17% compared to Genpact's net margin of 11.04%. ExlService's return on equity of 30.61% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
Genpact11.04% 23.34% 10.68%
ExlService 11.17%30.61%15.66%

Genpact has higher revenue and earnings than ExlService. Genpact is trading at a lower price-to-earnings ratio than ExlService, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genpact$5.25B1.21$552.49M$3.3711.19
ExlService$2.09B2.72$251.02M$1.5923.53

Genpact presently has a consensus price target of $39.33, indicating a potential upside of 4.33%. ExlService has a consensus price target of $44.50, indicating a potential upside of 18.92%. Given ExlService's stronger consensus rating and higher possible upside, analysts plainly believe ExlService is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22
ExlService
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Summary

ExlService beats Genpact on 12 of the 16 factors compared between the two stocks.

How does Genpact compare to Broadridge Financial Solutions?

Broadridge Financial Solutions (NYSE:BR) and Genpact (NYSE:G) are both industrials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Broadridge Financial Solutions has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Broadridge Financial Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Broadridge Financial Solutions$7.48B2.75$1.12B$9.6218.72
Genpact$5.25B1.21$552.49M$3.3711.19

In the previous week, Broadridge Financial Solutions had 11 more articles in the media than Genpact. MarketBeat recorded 26 mentions for Broadridge Financial Solutions and 15 mentions for Genpact. Broadridge Financial Solutions' average media sentiment score of 1.59 beat Genpact's score of 0.70 indicating that Broadridge Financial Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Broadridge Financial Solutions
22 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Genpact
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

90.0% of Broadridge Financial Solutions shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 1.1% of Broadridge Financial Solutions shares are held by company insiders. Comparatively, 1.6% of Genpact shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Broadridge Financial Solutions has a net margin of 15.04% compared to Genpact's net margin of 11.04%. Broadridge Financial Solutions' return on equity of 40.25% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
Broadridge Financial Solutions15.04% 40.25% 12.97%
Genpact 11.04%23.34%10.68%

Broadridge Financial Solutions presently has a consensus price target of $216.00, suggesting a potential upside of 19.95%. Genpact has a consensus price target of $39.33, suggesting a potential upside of 4.33%. Given Broadridge Financial Solutions' stronger consensus rating and higher possible upside, equities analysts plainly believe Broadridge Financial Solutions is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Broadridge Financial Solutions
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22

Broadridge Financial Solutions pays an annual dividend of $3.90 per share and has a dividend yield of 2.2%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.0%. Broadridge Financial Solutions pays out 40.5% of its earnings in the form of a dividend. Genpact pays out 22.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Broadridge Financial Solutions has raised its dividend for 18 consecutive years and Genpact has raised its dividend for 6 consecutive years. Broadridge Financial Solutions is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Broadridge Financial Solutions has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Genpact has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

Summary

Broadridge Financial Solutions beats Genpact on 16 of the 19 factors compared between the two stocks.

How does Genpact compare to SS&C Technologies?

SS&C Technologies (NASDAQ:SSNC) and Genpact (NYSE:G) are both industrials companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

SS&C Technologies presently has a consensus target price of $92.38, suggesting a potential upside of 12.78%. Genpact has a consensus target price of $39.33, suggesting a potential upside of 4.33%. Given SS&C Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe SS&C Technologies is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS&C Technologies
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.78
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22

SS&C Technologies has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS&C Technologies$6.27B3.06$796.90M$3.4823.54
Genpact$5.25B1.21$552.49M$3.3711.19

In the previous week, SS&C Technologies had 11 more articles in the media than Genpact. MarketBeat recorded 26 mentions for SS&C Technologies and 15 mentions for Genpact. SS&C Technologies' average media sentiment score of 1.65 beat Genpact's score of 0.70 indicating that SS&C Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS&C Technologies
24 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Genpact
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

SS&C Technologies pays an annual dividend of $1.08 per share and has a dividend yield of 1.3%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.0%. SS&C Technologies pays out 31.0% of its earnings in the form of a dividend. Genpact pays out 22.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SS&C Technologies has raised its dividend for 9 consecutive years and Genpact has raised its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and lower payout ratio.

96.9% of SS&C Technologies shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 16.0% of SS&C Technologies shares are held by insiders. Comparatively, 1.6% of Genpact shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SS&C Technologies has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, Genpact has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

SS&C Technologies has a net margin of 13.16% compared to Genpact's net margin of 11.04%. Genpact's return on equity of 23.34% beat SS&C Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
SS&C Technologies13.16% 21.20% 7.19%
Genpact 11.04%23.34%10.68%

Summary

SS&C Technologies beats Genpact on 16 of the 20 factors compared between the two stocks.

How does Genpact compare to Maximus?

Maximus (NYSE:MMS) and Genpact (NYSE:G) are both mid-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Genpact has a net margin of 11.04% compared to Maximus' net margin of 7.07%. Maximus' return on equity of 24.91% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
Maximus7.07% 24.91% 10.08%
Genpact 11.04%23.34%10.68%

Genpact has a consensus price target of $39.33, indicating a potential upside of 4.33%. Given Genpact's stronger consensus rating and higher probable upside, analysts plainly believe Genpact is more favorable than Maximus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maximus
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22

97.2% of Maximus shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 1.8% of Maximus shares are held by insiders. Comparatively, 1.6% of Genpact shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Genpact has lower revenue, but higher earnings than Maximus. Maximus is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maximus$5.43B0.56$319.03M$6.778.51
Genpact$5.25B1.21$552.49M$3.3711.19

In the previous week, Maximus had 2 more articles in the media than Genpact. MarketBeat recorded 17 mentions for Maximus and 15 mentions for Genpact. Genpact's average media sentiment score of 0.70 beat Maximus' score of 0.39 indicating that Genpact is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Maximus
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Genpact
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Maximus pays an annual dividend of $1.32 per share and has a dividend yield of 2.3%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.0%. Maximus pays out 19.5% of its earnings in the form of a dividend. Genpact pays out 22.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Maximus has increased its dividend for 2 consecutive years and Genpact has increased its dividend for 6 consecutive years. Maximus is clearly the better dividend stock, given its higher yield and lower payout ratio.

Maximus has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Genpact has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market.

Summary

Genpact beats Maximus on 10 of the 19 factors compared between the two stocks.

How does Genpact compare to Innodata?

Innodata (NASDAQ:INOD) and Genpact (NYSE:G) are both industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

Genpact has higher revenue and earnings than Innodata. Genpact is trading at a lower price-to-earnings ratio than Innodata, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innodata$251.66M7.46$32.18M$1.3241.39
Genpact$5.25B1.21$552.49M$3.3711.19

Innodata currently has a consensus price target of $130.00, indicating a potential upside of 137.92%. Genpact has a consensus price target of $39.33, indicating a potential upside of 4.33%. Given Innodata's stronger consensus rating and higher possible upside, equities analysts plainly believe Innodata is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innodata
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22

30.8% of Innodata shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 11.8% of Innodata shares are owned by company insiders. Comparatively, 1.6% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Innodata has a net margin of 14.66% compared to Genpact's net margin of 11.04%. Innodata's return on equity of 37.79% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
Innodata14.66% 37.79% 20.92%
Genpact 11.04%23.34%10.68%

Innodata has a beta of 2.88, indicating that its share price is 188% more volatile than the broader market. Comparatively, Genpact has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market.

In the previous week, Genpact had 12 more articles in the media than Innodata. MarketBeat recorded 15 mentions for Genpact and 3 mentions for Innodata. Innodata's average media sentiment score of 1.34 beat Genpact's score of 0.70 indicating that Innodata is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innodata
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Innodata beats Genpact on 11 of the 17 factors compared between the two stocks.

Get Genpact News Delivered to You Automatically

Sign up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

G vs. The Competition

MetricGenpactProfessional Services IndustryIndustrials SectorNYSE Exchange
Market Cap$6.38B$8.23B$10.46B$24.02B
Dividend Yield1.97%3.70%97.15%3.73%
P/E Ratio11.1937.4125.9929.40
Price / Sales1.2122.36377.7720.15
Price / Cash10.0022.9124.0832.44
Price / Book2.437.294.547.55
Net Income$552.49M$236.65M$611.46M$1.07B
7 Day Performance1.07%-1.79%-2.04%-1.95%
1 Month Performance7.19%2.18%0.31%0.58%
1 Year Performance-16.83%-6.34%9.38%11.90%

Genpact Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
G
Genpact
4.1701 of 5 stars
$37.70
-0.7%
$39.33
+4.3%
-16.8%$6.38B$5.25B11.19146,500
EXLS
ExlService
4.3854 of 5 stars
$38.08
-0.8%
$44.50
+16.9%
-14.5%$5.82B$2.09B23.9565,000
BR
Broadridge Financial Solutions
4.8971 of 5 stars
$182.76
-0.5%
$216.00
+18.2%
-29.6%$20.94B$7.48B19.0016,000
SSNC
SS&C Technologies
4.8637 of 5 stars
$82.97
-0.5%
$92.38
+11.3%
-7.6%$19.57B$6.56B23.8428,800
MMS
Maximus
1.9862 of 5 stars
$57.88
-3.1%
N/A-34.6%$3.13B$5.43B8.5537,200

Related Companies and Tools


This page (NYSE:G) was last updated on 9/2/2026 by MarketBeat.com Staff.
From Our Partners